Clinical Trial Update: Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating an ophthalmic solution for induced acute allergic conjunctivitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• Ophthalmic Solution

Snippet

Sponsor: Vistakon Pharmaceuticals | Conditions: Allergic Conjunctivitis | Phase 3 | Status: COMPLETED